Condition
    Moderate Evidence
    Effectiveness 2/5

    Vitamin D for Multiple Sclerosis

    Low vitamin D is one of the strongest environmental risk factors for developing MS, but supplementation trials in established disease have produced inconsistent MRI results and no clear disability benefit.

    Overview

    Low vitamin D is one of the strongest environmental risk factors for developing MS, but supplementation trials in established disease have produced inconsistent MRI results and no clear disability benefit.

    Verdict

    Mixed evidence

    Worth maintaining sufficiency given the risk-factor evidence and bone health needs. Not a substitute for disease-modifying therapy, and megadoses are not supported.

    How It Works

    Calcitriol acts on vitamin D receptors expressed by T cells, B cells and dendritic cells, promoting regulatory T cell development, suppressing Th1 and Th17 differentiation and reducing pro-inflammatory cytokine production. These are precisely the pathways implicated in MS lesion formation, which explains why the hypothesis has attracted so much investigation.

    Dosing & Protocol

    Typical dose

    Recommended dose
    2000-4000 IU daily to maintain sufficiency; higher doses only under neurological supervision
    Expected timeframe
    Serum levels correct in eight to twelve weeks. Any MRI or relapse effect would be assessed over one to two years.

    Protocol

    form
    Vitamin D3 (cholecalciferol)
    duration
    12-24 months with MRI lesion counts and relapse rates
    co factor
    Take with the largest meal. Evidence is mixed and worth separating: low vitamin D and low sun exposure are consistently associated with higher MS risk and higher relapse rates, and repletion is standard supportive care given the immobility-related bone risk. But the randomised trials of high-dose supplementation as add-on therapy - SOLAR and CHOLINE - failed to meet their primary endpoints for reducing disease activity.
    titration
    Check 25-hydroxyvitamin D and titrate to 75-125 nmol/L; MS trials have used high doses, and the SOLAR and CHOLINE trials tested up to 14,000 IU/day equivalents under supervision
    starting dose
    1000-4000 IU (25-100 mcg) vitamin D3 daily with a fat-containing meal, under neurology guidance

    Evidence

    What the studies say

    Epidemiology is strong and consistent. MS incidence follows a marked latitude gradient, low 25-OH-D in adolescence predicts later MS risk in large cohorts, and Mendelian randomisation studies support a causal contribution of genetically low vitamin D to disease susceptibility. Prospective cohorts in established relapsing MS link higher 25-OH-D with fewer new lesions and lower relapse rates. Randomised trials, however, have disappointed. SOLAR tested high-dose vitamin D added to interferon beta and missed its primary endpoint, though some MRI measures favoured treatment. CHOLINE and other trials produced similarly mixed results, and meta-analyses conclude there is no reliable effect on relapse rate or disability progression. The most coherent interpretation is that vitamin D matters for risk of developing MS, particularly in early life, more than for modifying disease already established.

    Vitamin D for the management of multiple sclerosis

    Score: 9/10
    2018
    systematic_review
    n=933

    Jagannath VA, et al

    To date, very low-quality evidence suggests no benefit of vitamin D for patient-important outcomes among people with MS.

    View source

    The efficacy of vitamin D in multiple sclerosis: A meta-analysis

    Score: 7/10
    2018
    meta_analysis

    Zheng C, et al

    Our findings suggest that vitamin D appeared to have no therapeutic effect on EDSS score or ARR in the patients with MS.

    View source

    Safety

    Caveats

    Very high doses risk hypercalcaemia without demonstrated benefit; the SOLAR-style regimens were supervised. Steroid pulses for relapses add bone risk, making sufficiency more important. Absorption is fat-dependent.

    Less likely to help if

    People already vitamin D replete, and anyone hoping it will substitute for disease-modifying therapy — the evidence does not support that trade.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.